loader
Please Wait
Applying Filters...

Seqens Seqens

X

Approved Drug Products containing 205613 listed in the FDA Orange Book. Original Data : FDA Website

Client Virtual Booth
Menu
Left Arrow
Right Arrow
Filters Filter
Cross PopUp
FILTER :

filter

01 SALIX (1)

filter

01 AEROSOL, FOAM;RECTAL (1)

filter

01 RX (1)

filter

01 UCERIS (1)

filter

01 Yes (1)

URL Supplier Web Content
AEROSOL, FOAM; REC...
2MG/ACTUATION
2014-10-07
205613
UCERIS
RX
Yes
AB
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for FDA Orange Book APPLICATION 205613

Looking for FDA Orange Book APPLICATION 205613 1

19

Salix Pharmaceuticals, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.

One of their notable products is BUDESONIDE, with a corresponding application number 205613.

Regulatory Information RX

With a dosage strength 2MG/ACTUATION

Dosage Form Route AEROSOL, FOAM; RECTAL

Reference Listed Drug Yes

Approved since 2014-10-07

Therapeutic Equivalence (TE) Code AB

Post Enquiry
POST ENQUIRY